Similar medications and substitutes for TISAGENLECLEUCEL
In short: Kymriah (TISAGENLECLEUCEL) belongs to the CD19-directed Chimeric Antigen Receptor class. The medications listed below either share that mechanism of action or have been clinically validated as substitutes when Kymriah is unsuitable due to side effects, cost, availability, or contraindications.
No alternatives are listed for Kymriah in our database yet. Browse the full medicine index or consult your pharmacist for substitution advice.